Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Oppenheimer reiterated its Outperform rating on Tarsus Pharmaceuticals, Inc. Common Stock (NASDAQ:TARS) on August 12, 2026.
Read moreBarclays reiterated its Equal-Weight rating on Aecom (NYSE:ACM) on August 12, 2026.
Read moreKeybanc reiterated its Overweight rating on Aecom (NYSE:ACM) on August 12, 2026.
Read moreCitigroup reiterated its Buy rating on Aecom (NYSE:ACM) on August 12, 2026.
Read moreTruist Securities reiterated its Buy rating on Aecom (NYSE:ACM) on August 12, 2026.
Read moreWells Fargo reiterated its Equal-Weight rating on Lamar Advertising Company (NASDAQ:LAMR) on August 12, 2026.
Read moreLeerink Partners analysts upgraded Summit Therapeutics Inc. (NASDAQ:SMMT) from Underperform to Market Perform on August 12, 2026.
Read moreMizuho analysts upgraded IDEX Corporation (NYSE:IEX) from Neutral to Outperform on August 12, 2026.
Read moreJP Morgan reiterated its Overweight rating on BridgeBio Pharma, Inc. (NASDAQ:BBIO) on August 12, 2026.
Read moreTruist Securities reiterated its Buy rating on BridgeBio Pharma, Inc. (NASDAQ:BBIO) on August 12, 2026.
Read moreCanaccord Genuity reiterated its Buy rating on BridgeBio Pharma, Inc. (NASDAQ:BBIO) on August 12, 2026.
Read moreDeutsche Bank analysts upgraded Entegris, Inc. (NASDAQ:ENTG) from Hold to Buy on August 12, 2026.
Read moreSusquehanna reiterated its Neutral rating on Joint Stock Company Kaspi.kz (NASDAQ:KSPI) on August 12, 2026.
Read moreJP Morgan analysts initiated coverage on Flutter Entertainment plc (NYSE:FLUT) with a rating of Neutral on August 12, 2026.
Read moreBaird reiterated its Outperform rating on Cardinal Health, Inc. (NYSE:CAH) on August 12, 2026.
Read moreWells Fargo reiterated its Overweight rating on Cardinal Health, Inc. (NYSE:CAH) on August 12, 2026.
Read moreMizuho reiterated its Outperform rating on Cardinal Health, Inc. (NYSE:CAH) on August 12, 2026.
Read moreUBS reiterated its Buy rating on Cardinal Health, Inc. (NYSE:CAH) on August 12, 2026.
Read moreCitigroup reiterated its Buy rating on Cardinal Health, Inc. (NYSE:CAH) on August 12, 2026.
Read moreEvercore ISI Group reiterated its Outperform rating on Cardinal Health, Inc. (NYSE:CAH) on August 12, 2026.
Read more
